|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcino- ma显示文摘 | Atkins MB Hidalgo M Stadler WM | 2004 | J Clin Oncol2004，22，5： | 1 |
| 2 | Randomized phase Ⅱ study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor in patients with advanced re- fractory renal cell carcinoma 显示文摘 | Atkins MB Hidalgo M Stadler WM | 2004 | J Clin Oncol2004，22，5： | 1 |
| 3 | Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma 显示文摘 | Atkins MB Hidalgo M Stadler WM | 2004 | J Clin Oncol2004，22，5： | 1 |
| 4 | Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamyein kinase inhibitor, in patients with advanced refractory renal cell carcinoma显示文摘 | Atkins MB Hidalgo M Stadler WM | 2004 | J Clin Oncol2004，22，： | 1 |
| 5 | Conformational analysis of human ATP-binding cassette transporter ABCB1 in lipid nanodiscs and inhibition by the antibodies MRK16 and UIC2 显示文摘 | Ritchie TK Kwon H Atkins WM | 2011 | J Biol Chem2011，286，39： | 1 |
| 6 | Randomized phase lI study of multiple dose levels of CCI-779, a novel mammalian tar- get of rapamycin kinase inhibitor, in patients with advanced re- fractory renal cell carcinoma显示文摘 | Atkins MB Hidalgo M Stadler WM | 2004 | J Clin Oncol2004，22，5： | 1 |
| 7 | A theoretical validation of the substrate deple- tion approach to determining kinetic parameters 显示文摘 | Nath A Atkins WM | 2006 | Drug Metab Dispos2006，34，9： | 1 |
| 8 | Randomized phase Ⅱ study of multiple does levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with ad- vanced refractory renal cell carcinomal 显示文摘 | ATKINS M B HIDALGO M STADLER WM | 2004 | J Clin Oncol2004，22，5： | 1 |
| 9 | Endoscopic repair of cerebrospinal fluid rhinorrhea显示文摘 | Mao VH Keane WM Atkins JP | 2000 | Otolaryngol Head Neck Surg2000，122，1： | 1 |
| 10 | Randomized phase II study of multiple dose levels of CCI-779,a novel mammalian target of rapamycin kinase inhibitor,in patients with advanced refractory renal cell careinoma显示文摘 | Atkins MB Hidalgo M Stadler WM | 2004 | J Clin Oncoi2004，22，5： | 1 |
| 11 | Randomized Phase Ⅱ study of multiple dose levels of CCI-779,a novel mammalian target of rapamycin kinase inhibitor,hi patients with advanced refractory renal cell carcinoma显示文摘 | Atkins MB Hidalgo M Stadler WM | 2004 | J Clin Oncol2004，22，5： | 1 |
| 12 | Randomized phase study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanccd refractory renal cell carcinoma 显示文摘 | Atkins MB Hidalgo M Stadler WM | 2004 | J Clin Oncol2004，22，5： | 1 |
| 13 | Randomized phase Ⅱ study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced trfractory renal cell carcinoma 显示文摘 | Atkins MB Hidalgo M Stadler WM | 2004 | J Clin Oncol2004，22，： | 1 |
| 14 | Randomized Phase Ⅱ study of multiple dose levels of GCI-779, a novel mammalian target of rapamycin kinase inhibitor,in patients with advanced refractory renal cell carcinoma显示文摘 | Atkins MB Hidalgo M Stadler WM | 2004 | J Clin Oncol2004，22，5： | 1 |
| 15 | Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes:the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial显示文摘 | Vogel VG Costantino JP Wickerham DL Cronin WM Cecchini RS Atkins JN | | 0，，： | 1 |
| 16 | Randomized phase Ⅱ study of multiple dose levels of CCI-779,a novel mammalian target of rapamycin kinase inhibitor,in patients with advanced refractory renal cell carcinoma显示文摘 | Atkins MB Hidalgo M Stadler WM | 2004 | J Clin Oncol2004，22，5： | 1 |
| 17 | Endoscopic repair of cerebrospinal fluid rhinorrhea显示文摘 | Mao VH Keane WM Atkins JP | 2000 | Otolaryngol Head Neck Surg2000，122，1： | 1 |
| 18 | Randomized phase Ⅱ study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma 显示文摘 | Atkins MB Hidalgo M Stadler WM | 2004 | J Clin Oncol2004，22，： | 1 |
| 19 | Endoscopic repair of cere-brospinal fluid rhinorrhea 显示文摘 | Mao VH Keane WM Atkins JP | 2000 | Otolaryngology Head Neck Surg2000，122，： | 1 |
| 20 | Randomized phase lI study of multiple dose levels of CCI-779, a novel mammalian target of Rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma显示文摘 | Atkins MB Hidalgo M Stadler WM | 2004 | J Clin Oncol2004，22，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员